World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

Michael Bauer, Andrea Pfennig, Emanuel Severus, Peter C. Whybrow, Jules Angst, Hans Jürgen Möller, Mazda Adli, Otto Benkert, Tom Bschor, André Tadić, Edith Holsboer-Trachsler, Ian Anderson, David Baldwin, John C. Cookson, Heinz Grunze, Cornelius Katona, Eugene S. Paykel, Andre Tylee, José L. Ayuso-Gutierrez, Eduard VietaPer Bech, Rasmus W. Licht, Henrik Lublin, Per Vestergaard, Michael Berk, Graham Burrows, Philip B. Mitchell, Isaac Schweitzer, Istvan Bitter, Giovanni Cassano, Marcelo Cetkovich-Bakmas, Delcir Da Costa, Mihai D. Gheorghe, Gerardo Heinze, Teruhiko Higuchi, Robert M.A. Hirschfeld, Martin B. Keller, David J. Kupfer, A. John Rush, Jürgen Unützer, Cyril Höschl, Rhee Hun Kang, Min Soo Lee, Se Won Lim, Jong Woo Paik, Yong Chon Park, Siegfried Kasper, Selcuk Kirli, Aylin Yazici, E. Kostukova, Parmanand Kulhara, Brian Leonard, Odd Lingjaerde, Chia Yih Liu, Julien Mendlewicz, Stanislaw Puzynski, Janusz K. Rybakowski, Kazuo Yamada

Research output: Contribution to journalArticle

267 Scopus citations

Abstract

Objectives. This 2013 update of the practice guidelines for the biological treatment of unipolar depressive disorders was developed by an international Task Force of the World Federation of Societies of Biological Psychiatry (WFSBP). The goal has been to systematically review all available evidence pertaining to the treatment of unipolar depressive disorders, and to produce a series of practice recommendations that are clinically and scientifically meaningful based on the available evidence. The guidelines are intended for use by all physicians seeing and treating patients with these conditions. Methods. The 2013 update was conducted by a systematic update literature search and appraisal. All recommendations were approved by the Guidelines Task Force. Results. This first part of the guidelines (Part 1) covers disease definition, classification, epidemiology, and course of unipolar depressive disorders, as well as the management of the acute and continuation phase treatment. It is primarily concerned with the biological treatment (including antidepressants, other psychopharmacological medications, electroconvulsive therapy, light therapy, adjunctive and novel therapeutic strategies) of adults. Conclusions. To date, there is a variety of evidence-based antidepressant treatment options available. Nevertheless there is still a substantial proportion of patients not achieving full remission. In addition, somatic and psychiatric comorbidities and other special circumstances need to be more thoroughly investigated. Therefore, further high-quality informative randomized controlled trials are urgently needed.

Original languageEnglish (US)
Pages (from-to)334-385
Number of pages52
JournalWorld Journal of Biological Psychiatry
Volume14
Issue number5
DOIs
StatePublished - Jul 1 2013

    Fingerprint

Keywords

  • Acute treatment
  • Antidepressants
  • Continuation treatment
  • Major depressive disorder
  • Pharmacotherapy

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H. J., Adli, M., Benkert, O., Bschor, T., Tadić, A., Holsboer-Trachsler, E., Anderson, I., Baldwin, D., Cookson, J. C., Grunze, H., Katona, C., Paykel, E. S., Tylee, A., Ayuso-Gutierrez, J. L., ... Yamada, K. (2013). World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders. World Journal of Biological Psychiatry, 14(5), 334-385. https://doi.org/10.3109/15622975.2013.804195